The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.

NCT04328480 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1279

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Colchicine
OTHER: Local standard of care

Sponsor

Estudios Clínicos Latino América

Collaborators

[object Object]